查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1744684

2032 年機器人放射腫瘤學市場預測：按產品、技術、應用、最終用戶和地區進行的全球分析

Robotic Radiotherapy Market Forecasts to 2032 - Global Analysis By Product, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球機器人放射治療市場預計在 2025 年將達到 14 億美元，預計到 2032 年將達到 35 億美元，預測期內的複合年成長率為 13.8%。

機器人放射治療是一種先進的癌症治療方法，利用機器人系統精準地向腫瘤發射高劑量的放射線，同時最大限度地減少對周圍健康組織的照射。它整合了即時影像處理和自適應運動追蹤技術，即使在動態解剖區域也能實現精準定位。此技術可提高治療效果並減少副作用，是複雜或難以觸及的腫瘤的理想選擇。機器人放射治療常用於立體定位放射治療 (SBRT)，透過提高精準度、效率和個人化治療方案來改善患者預後。

根據美國國家生物技術資訊中心（NCBI）的數據，2010年至2014年，有12個中心進行機器人手術，佔總數的18%，但到了2014年，這一數字已增至39個，佔使用機器人手術中心的71%。

全球癌症發生率上升

早期診斷技術的進步以及人口老化導致各種癌症更容易發生，促使醫療保健提供者採用主導治療方法。機器人放射治療可以實現精準放射，最大限度地減少對健康組織的損傷，同時提高治療效果。此外，個人化腫瘤治療意識的不斷增強，也促使醫院和研究中心將機器人輔助解決方案納入傳統的放射治療方案中。

複雜操作

即時影像處理、自適應運動追蹤和自動化精密控制的整合需要專業知識才能實現無縫運作。醫療機構通常難以應對機器人系統帶來的高額前期投資和漫長的學習週期。此外，維護和校準程序需要精通技術，這限制了它們在醫療基礎設施有限的地區普及。

機器人放射治療在非癌症疾病的興起

機器人放射治療不僅在癌症治療中日益普及，在動靜脈畸形、三叉神經痛、功能性疾病等非癌症疾病的治療中也日益普及。它能夠以毫米級的精度發射高劑量輻射，非常適合需要微創干預的病例。神經內科和整形外科的應用研究正在拓展機器人放射治療的應用範圍，同時，在慢性疼痛管理和血管異常治療方面取得的良好成果也推動著市場的成長。

來自替代療法的競爭

質子治療、免疫療法和先進手術機器人等技術正在成為癌症和神經系統疾病的可行替代療法。此外，隨著人工智慧最佳化和增強成像技術的融入，傳統的放射治療方法也不斷改進。醫療機構在選擇治療方法時，優先考慮成本效益、患者治療結果和基礎設施適用性等因素，阻礙了市場的成長。

COVID-19的影響：

疫情改變了醫療保健的重點，由於資源被分配到急救和感染疾病控制，機器人放射治療的需求暫時受到影響。然而，這場危機加速了遠端醫療和遠端患者監護，間接提升了人們對機器人輔助治療的興趣。隨著醫院恢復擇期手術，精準放射治療的需求也隨之增加。

放射治療系統部門預計將成為預測期內最大的部門

由於放射治療系統在腫瘤中心和醫院的廣泛應用，預計將在預測期內佔據最大的市場佔有率。這些系統整合了機器人高精度、即時影像處理和自動化治療計劃功能，以提高治療準確性。它們能夠簡化工作流程並減輕患者不適，使其成為放射腫瘤學領域的首選。

粒子束治療領域預計在預測期內達到最高複合年成長率

在預測期內，受質子治療和重離子治療技術進步的推動，粒子治療領域預計將實現最高成長率。這些治療方法因其卓越的腫瘤靶向性以及更低的副作用，在敏感癌症病例中越來越受到青睞。在粒子治療中，機器人的精準性進一步提高了治療效果，並實現了持續的給藥。隨著研究檢驗粒子治療的優勢，隨著醫院和研究機構將粒子治療系統納入其腫瘤治療項目，預計粒子治療市場將進一步擴大。

佔比最大的地區：

在預測期內，由於醫療基礎設施的不斷擴張和技術的進步，亞太地區預計將佔據最大的市場佔有率。中國、日本和印度等國家正大力投資腫瘤治療解決方案，推動機器人放射治療的需求。政府推動癌症早期發現和非侵入性治療方法的舉措進一步推動了機器人放射治療的普及。此外，醫療設備製造商和醫療保健提供者之間的合作正在加速全部區域機器人放射治療系統的開發和普及。

複合年成長率最高的地區：

在預測期內，由於放射治療技術的不斷創新和強大的研發投入，北美預計將呈現最高的複合年成長率。該地區成熟的醫療生態系統支持機器人精準治療與腫瘤治療的整合。領先的醫療機構正積極進行臨床試驗，以提升機器人放射治療的療效，進而促進市場擴張。

提供免費客製化

訂閱此報告的客戶可享有以下免費自訂選項之一：

  • 公司簡介
    • 對其他市場公司（最多 3 家公司）進行全面分析
    • 主要企業的SWOT分析（最多3家公司）
  • 地理細分
    • 根據客戶興趣對主要國家市場進行估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 限制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球機器人放射腫瘤學市場（按產品）

  • 放射治療系統
    • 電腦刀
    • 伽瑪刀
    • 具有機器人患者定位的直線加速器 (LINAC)
  • 軟體
    • 治療計劃系統（TPS）
    • 影像導航放射治療(IGRT) 軟體
    • 自適應放射治療 (ART) 軟體
  • 3D 攝影機（表面導引放射治療 - SGRT）
  • 其他產品

6. 全球機器人放射治療市場（依技術）

  • 線性加速器（LINAC）
  • 立體定位放射治療（SRT）系統
  • 粒子束治療
  • 影像導航放射治療(IGRT)
  • 強度調控放射治療(IMRT)
  • 其他技術

7. 全球機器人放射治療市場（依應用）

  • 肺癌和攝護腺癌
  • 乳癌和結腸癌
  • 腦和脊髓腫瘤
  • 肝癌和胰臟癌
  • 其他用途

8. 全球機器人放射治療市場（依最終用戶）

  • 醫院
  • 癌症研究所
  • 門診手術中心
  • 專科診所
  • 學術研究所
  • 其他最終用戶

9. 全球機器人放射治療市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第10章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司概況

  • Accuray Incorporated
  • Varian Medical Systems
  • Elekta AB
  • Mevion Medical Systems
  • Hitachi Ltd.
  • ViewRay Inc.
  • IBA Group
  • Reflexion Medical
  • Theragenics Corporation
  • Medtronic
  • CIVCO Radiotherapy
  • Bionix Radiation Therapy
  • Zap Surgical Systems
  • Mitsubishi Electric Corporation
  • RaySearch Laboratories
  • Sumitomo Heavy Industries
  • Nordion Inc.
  • P-Cure Ltd.
Product Code: SMRC29732

According to Stratistics MRC, the Global Robotic Radiotherapy Market is accounted for $1.4 billion in 2025 and is expected to reach $3.5 billion by 2032 growing at a CAGR of 13.8% during the forecast period. Robotic radiotherapy is an advanced cancer treatment method that utilizes robotic systems to deliver precise, high-dose radiation to tumors while minimizing exposure to surrounding healthy tissues. Integrating real-time imaging and adaptive motion tracking, it ensures accurate targeting even in dynamic anatomical regions. This technology enhances treatment efficacy and reduces side effects, making it ideal for complex or hard-to-reach tumors. Commonly used in stereotactic body radiotherapy (SBRT), robotic radiotherapy improves patient outcomes through increased precision, efficiency, and personalized treatment delivery.

According to the National Center for Biotechnology Information (NCBI), from 2010 to 2014, 12 centers practicing robotic surgery represented 18% of the total while by 2014 this number grew to 39 centers which made up 71% of centers utilizing robotic surgery thus demonstrating rapid industry-wide adoption.

Market Dynamics:

Driver:

Increasing global cancer prevalence

The advancements in early diagnosis and an aging population susceptible to various cancer types, healthcare providers are increasingly adopting precision-driven treatment methods. Robotic radiotherapy enables targeted radiation delivery, minimizing damage to healthy tissues while improving therapeutic efficacy. Additionally, the growing awareness of personalized oncology care is prompting hospitals and research centers to integrate robotic-assisted solutions into conventional radiotherapy protocols.

Restraint:

Complexity of operation

The integration of real-time imaging, adaptive motion tracking, and automated precision control requires specialized expertise for seamless operation. Healthcare facilities often struggle with the high initial investment and extended learning curve associated with robotic systems. Moreover, maintenance and calibration procedures demand technical proficiency, limiting accessibility in regions with constrained medical infrastructure.

Opportunity:

Increasing use of robotic radiotherapy for non-cancerous conditions

Beyond oncology, robotic radiotherapy is gaining traction in treating non-cancerous conditions such as arteriovenous malformations, trigeminal neuralgia, and functional disorders. Its ability to deliver high-dose radiation with millimeter precision makes it suitable for cases requiring minimally invasive intervention. Research in neurology and orthopedic applications is expanding the scope of robotic radiotherapy, with promising outcomes for chronic pain management and vascular abnormalities boost the market growth.

Threat:

Competition from alternative therapies

Technologies like proton therapy, immunotherapy, and advanced surgical robotics are emerging as viable alternatives for cancer and neurological disorders. Additionally, traditional radiotherapy methods continue to improve, incorporating AI-driven optimization and enhanced imaging techniques. Healthcare institutions weigh factors such as cost-effectiveness, patient outcomes, and infrastructure compatibility when selecting treatment approaches hamper the market growth.

Covid-19 Impact:

The pandemic reshape healthcare priorities, temporarily affecting the demand for robotic radiotherapy due to resource allocation towards emergency care and infection control. However, the crisis also accelerated telemedicine adoption and remote patient monitoring, indirectly boosting interest in robotic-assisted treatment. As hospitals resumed elective procedures, the need for precision-driven radiotherapy gained momentum.

The radiotherapy systems segment is expected to be the largest during the forecast period

The radiotherapy systems segment is expected to account for the largest market share during the forecast period driven by widespread adoption in oncology centers and hospitals. These systems integrate robotic precision, real-time imaging, and automated treatment planning, enhancing therapeutic accuracy. Their ability to streamline workflows and reduce patient discomfort makes them a preferred choice for radiation oncology.

The particle therapy segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the particle therapy segment is predicted to witness the highest growth rate propelled by innovations in proton and heavy-ion therapy. These modalities offer superior tumor targeting with reduced side effects, making them increasingly favorable for sensitive cancer cases. Robotic precision further enhances treatment delivery in particle therapy, ensuring consistent radiation dosing. As research validates its advantages, market expansion is expected, with hospitals and research institutions incorporating particle therapy systems into oncology programs.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share owing to expanding healthcare infrastructure, and technological advancements. Countries such as China, Japan, and India are investing heavily in oncology solutions, fostering demand for robotic radiotherapy. Government initiatives promoting early cancer detection and non-invasive treatment approaches are further strengthening adoption. Additionally, collaborations between medical device manufacturers and healthcare providers are accelerating the development and deployment of robotic radiotherapy systems across the region.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR driven by continuous innovation in radiotherapy technologies and strong research investments. The region's well-established healthcare ecosystem supports the integration of robotic precision in oncology treatments. Leading institutions are actively conducting clinical trials to enhance the efficacy of robotic radiotherapy, contributing to market expansion.

Key players in the market

Some of the key players in Robotic Radiotherapy Market include Accuray Incorporated, Varian Medical Systems, Elekta AB, Mevion Medical Systems, Hitachi Ltd., ViewRay Inc., IBA Group, Reflexion Medical, Theragenics Corporation, Medtronic, CIVCO Radiotherapy, Bionix Radiation Therapy, Zap Surgical Systems, Mitsubishi Electric Corporation, RaySearch Laboratories, Sumitomo Heavy Industries, Nordion Inc., and P-Cure Ltd.

Key Developments:

In May 2025, Varian Medical Systems expanded its ten-year strategic collaboration with MedServe - NSIA Advanced Medical Services Limited to enhance cancer care services in Nigeria.

In May 2025, IBA Group signed a contract with PET Pharm Bio to install a Cyclone(R) IKON in Taiwan, expanding its cyclotron technology footprint in Asia.

In April 2025, Mitsubishi Electric Corporation signed an agreement with HD Renewable Energy to establish a joint venture in Japan, focusing on renewable energy solutions.

Products Covered:

  • Radiotherapy Systems
  • Software
  • 3D Cameras (Surface Guided Radiation Therapy - SGRT)
  • Other Products

Technologies Covered:

  • Linear Accelerators (LINACs)
  • Stereotactic Radiation Therapy (SRT) Systems
  • Particle Therapy
  • Image-Guided Radiation Therapy (IGRT)
  • Intensity-Modulated Radiation Therapy (IMRT)
  • Other Technologies

Applications Covered:

  • Lung Cancer & Prostate Cancer
  • Breast Cancer & Colorectal Cancer
  • Brain Tumors & Spinal Tumors
  • Liver Cancer & Pancreatic Cancer
  • Other Applications

End Users Covered:

  • Hospitals
  • Cancer Research Institutes
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Academic & Research Institutions
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Robotic Radiotherapy Market, By Product

  • 5.1 Introduction
  • 5.2 Radiotherapy Systems
    • 5.2.1 CyberKnife
    • 5.2.2 Gamma Knife
    • 5.2.3 Linear Accelerators (LINACs) with Robotic Patient Positioning
  • 5.3 Software
    • 5.3.1 Treatment Planning Systems (TPS)
    • 5.3.2 Image-Guided Radiation Therapy (IGRT) software
    • 5.3.3 Adaptive Radiotherapy (ART) software
  • 5.4 3D Cameras (Surface Guided Radiation Therapy - SGRT)
  • 5.5 Other Products

6 Global Robotic Radiotherapy Market, By Technology

  • 6.1 Introduction
  • 6.2 Linear Accelerators (LINACs)
  • 6.3 Stereotactic Radiation Therapy (SRT) Systems
  • 6.4 Particle Therapy
  • 6.5 Image-Guided Radiation Therapy (IGRT)
  • 6.6 Intensity-Modulated Radiation Therapy (IMRT)
  • 6.7 Other Technologies

7 Global Robotic Radiotherapy Market, By Application

  • 7.1 Introduction
  • 7.2 Lung Cancer & Prostate Cancer
  • 7.3 Breast Cancer & Colorectal Cancer
  • 7.4 Brain Tumors & Spinal Tumors
  • 7.5 Liver Cancer & Pancreatic Cancer
  • 7.6 Other Applications

8 Global Robotic Radiotherapy Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Cancer Research Institutes
  • 8.4 Ambulatory Surgical Centers
  • 8.5 Specialty Clinics
  • 8.6 Academic & Research Institutions
  • 8.7 Other End Users

9 Global Robotic Radiotherapy Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Accuray Incorporated
  • 11.2 Varian Medical Systems
  • 11.3 Elekta AB
  • 11.4 Mevion Medical Systems
  • 11.5 Hitachi Ltd.
  • 11.6 ViewRay Inc.
  • 11.7 IBA Group
  • 11.8 Reflexion Medical
  • 11.9 Theragenics Corporation
  • 11.10 Medtronic
  • 11.11 CIVCO Radiotherapy
  • 11.12 Bionix Radiation Therapy
  • 11.13 Zap Surgical Systems
  • 11.14 Mitsubishi Electric Corporation
  • 11.15 RaySearch Laboratories
  • 11.16 Sumitomo Heavy Industries
  • 11.17 Nordion Inc.
  • 11.18 P-Cure Ltd.

List of Tables

  • Table 1 Global Robotic Radiotherapy Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Robotic Radiotherapy Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Robotic Radiotherapy Market Outlook, By Radiotherapy Systems (2024-2032) ($MN)
  • Table 4 Global Robotic Radiotherapy Market Outlook, By CyberKnife (2024-2032) ($MN)
  • Table 5 Global Robotic Radiotherapy Market Outlook, By Gamma Knife (2024-2032) ($MN)
  • Table 6 Global Robotic Radiotherapy Market Outlook, By Linear Accelerators (LINACs) with Robotic Patient Positioning (2024-2032) ($MN)
  • Table 7 Global Robotic Radiotherapy Market Outlook, By Software (2024-2032) ($MN)
  • Table 8 Global Robotic Radiotherapy Market Outlook, By Treatment Planning Systems (TPS) (2024-2032) ($MN)
  • Table 9 Global Robotic Radiotherapy Market Outlook, By Image-Guided Radiation Therapy (IGRT) software (2024-2032) ($MN)
  • Table 10 Global Robotic Radiotherapy Market Outlook, By Adaptive Radiotherapy (ART) software (2024-2032) ($MN)
  • Table 11 Global Robotic Radiotherapy Market Outlook, By 3D Cameras (Surface Guided Radiation Therapy - SGRT) (2024-2032) ($MN)
  • Table 12 Global Robotic Radiotherapy Market Outlook, By Other Products (2024-2032) ($MN)
  • Table 13 Global Robotic Radiotherapy Market Outlook, By Technology (2024-2032) ($MN)
  • Table 14 Global Robotic Radiotherapy Market Outlook, By Linear Accelerators (LINACs) (2024-2032) ($MN)
  • Table 15 Global Robotic Radiotherapy Market Outlook, By Stereotactic Radiation Therapy (SRT) Systems (2024-2032) ($MN)
  • Table 16 Global Robotic Radiotherapy Market Outlook, By Particle Therapy (2024-2032) ($MN)
  • Table 17 Global Robotic Radiotherapy Market Outlook, By Image-Guided Radiation Therapy (IGRT) (2024-2032) ($MN)
  • Table 18 Global Robotic Radiotherapy Market Outlook, By Intensity-Modulated Radiation Therapy (IMRT) (2024-2032) ($MN)
  • Table 19 Global Robotic Radiotherapy Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 20 Global Robotic Radiotherapy Market Outlook, By Application (2024-2032) ($MN)
  • Table 21 Global Robotic Radiotherapy Market Outlook, By Lung Cancer & Prostate Cancer (2024-2032) ($MN)
  • Table 22 Global Robotic Radiotherapy Market Outlook, By Breast Cancer & Colorectal Cancer (2024-2032) ($MN)
  • Table 23 Global Robotic Radiotherapy Market Outlook, By Brain Tumors & Spinal Tumors (2024-2032) ($MN)
  • Table 24 Global Robotic Radiotherapy Market Outlook, By Liver Cancer & Pancreatic Cancer (2024-2032) ($MN)
  • Table 25 Global Robotic Radiotherapy Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 26 Global Robotic Radiotherapy Market Outlook, By End User (2024-2032) ($MN)
  • Table 27 Global Robotic Radiotherapy Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 28 Global Robotic Radiotherapy Market Outlook, By Cancer Research Institutes (2024-2032) ($MN)
  • Table 29 Global Robotic Radiotherapy Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 30 Global Robotic Radiotherapy Market Outlook, By Specialty Clinics (2024-2032) ($MN)
  • Table 31 Global Robotic Radiotherapy Market Outlook, By Academic & Research Institutions (2024-2032) ($MN)
  • Table 32 Global Robotic Radiotherapy Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.